CATHY ADAMSON: Open Payments
NPI 1407906126 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 31 payments from 17 companies in 2025. Trend: 2023 $1,263 · 2024 $1,466 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $239 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Amgen Inc. | 3 | $57 |
| Abbott Laboratories | 2 | $55 |
| SCPHARMACEUTICALS INC. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $37 |
| CVRx, Inc. | 1 | $29 |
| Elutia, Inc. | 3 | $26 |
| Edwards Lifesciences Corporation | 1 | $22 |
Products named: WATCHMAN FLX, CAMZYOS, REPATHA, FUROSCIX, LEQVIO, LifeVest, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System.
Industry payments across IL — which companies pay providers there.
